Review ArticleReviews and Contemporary Updates

Mechanical Circulatory Support for the Failing Heart: Continuous-Flow Left Ventricular Assist Devices

Joseph A. R. Englert, Jennifer A. Davis and Selim R. Krim
Ochsner Journal September 2016, 16 (3) 263-269;

Article Figures & Data

Figures

  • Figure 1.
    Figure 1.

    Landmark events in the development of left ventricular assist devices and cardiac transplantation. FDA, US Food and Drug Administration; LVAD, left ventricular assist device; REMATCH, Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure.

  • Figure 2.
    Figure 2.

    Left ventricular assist devices currently available in the United States. aThe HVAD trial for the DT indication was completed in 2015 and is awaiting FDA approval. bThe trial ongoing in 2016 for BTT and DT indications is the Momentum 3. BTT, bridge to transplantation; DT, destination therapy; FDA, US Food and Drug Administration. Images reproduced with permission from Thoratec Corp. and HeartWare.

  • Figure 3.
    Figure 3.

    Basic left ventricular assist device components. Image reproduced with permission from Thoratec Corp.

Tables

  • Table 1.
  • Table 2.
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords